Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Hisse Senetlerindeki Sıralama #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Hisse Fiyatı
$0.2219522
Son senkronizasyon: 2025-09-11
Piyasa Değeri
$1.10B
Değişim (1 gün)
0.04%
Değişim (1 yıl)
0.17%
Ülke
CN
Ticaret Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Hubei Biocause Pharmaceutical Co., Ltd. (000627) için gelir
Sep 2024 itibarıyla gelir TTM: $11.64B
Hubei Biocause Pharmaceutical Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $11.64B'dir. 2022 yılında şirketin geliri $7.19B önceki yıla göre azalma 2021 yılındaki $7.80B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Hubei Biocause Pharmaceutical Co., Ltd. için 2000 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $11.64B 65.85%
2023 $7.02B -2.39%
2022 $7.19B -7.80%
2021 $7.80B 16.95%
2020 $6.67B -7.46%
2019 $7.21B 60.19%
2018 $4.50B -45.18%
2017 $8.21B 235.32%
2016 $2.45B 2,837.70%
2015 $83.33M -36.00%
2014 $130.20M -18.41%
2013 $159.58M 27.62%
2012 $125.04M -30.47%
2011 $179.84M -5.88%
2010 $191.07M 35.24%
2009 $141.29M 6.03%
2008 $133.26M 16.42%
2007 $114.46M 59.34%
2006 $71.83M 11.78%
2005 $64.26M 14.85%
2004 $55.95M 9.55%
2003 $51.07M 21.26%
2002 $42.12M -2.10%
2001 $43.02M 10.51%
2000 $38.93M 0.00%
Benzer şirketler veya rakiplerin geliri